These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 22522930)

  • 1. Osteoprotection by semaphorin 3A.
    Hayashi M; Nakashima T; Taniguchi M; Kodama T; Kumanogoh A; Takayanagi H
    Nature; 2012 May; 485(7396):69-74. PubMed ID: 22522930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-196b-5p Regulates Osteoblast and Osteoclast Differentiation and Bone Homeostasis by Targeting SEMA3A.
    Xie Y; Zhou J; Tian L; Dong Y; Yuan H; Zhu E; Li X; Wang B
    J Bone Miner Res; 2023 Aug; 38(8):1175-1191. PubMed ID: 37221130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A.
    de Ridder D; Marino S; Bishop RT; Renema N; Chenu C; Heymann D; Idris AI
    Sci Rep; 2018 May; 8(1):6877. PubMed ID: 29720701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Potential Role of Semaphorin 3A during Orthodontic Tooth Movement.
    Şen S; Lux CJ; Erber R
    Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosmarinic acid exerts an antiosteoporotic effect in the RANKL-induced mouse model of bone loss by promotion of osteoblastic differentiation and inhibition of osteoclastic differentiation.
    Lee JW; Asai M; Jeon SK; Iimura T; Yonezawa T; Cha BY; Woo JT; Yamaguchi A
    Mol Nutr Food Res; 2015 Mar; 59(3):386-400. PubMed ID: 25380345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway.
    Xing Q; Feng J; Zhang X
    Exp Cell Res; 2021 Jun; 403(1):112595. PubMed ID: 33838126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.
    Lotz EM; Berger MB; Boyan BD; Schwartz Z
    Bone; 2020 May; 134():115260. PubMed ID: 32028017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model.
    Deng J; Cohen DJ; Sabalewski EL; Van Duyn C; Wilson DS; Schwartz Z; Boyan BD
    Acta Biomater; 2023 Feb; 157():236-251. PubMed ID: 36435442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral nerve-derived Sema3A promotes osteogenic differentiation of mesenchymal stem cells through the Wnt/β-catenin/Nrp1 positive feedback loop.
    Shi J; Zhang B; Wu Z; Zhang Y; Gupta A; Wang X; Wang J; Pan L; Xiao M; Zhang S; Wang L
    J Cell Mol Med; 2024 Apr; 28(8):e18201. PubMed ID: 38568078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin Stimulates Proliferation and Inhibits Late Differentiation of Primary Rat Calvarial Osteoblast Induced by High-dose Dexamethasone via Sema3A /NRP1/Pleixin A1.
    Zheng L
    Curr Pharm Biotechnol; 2021; 22(11):1538-1545. PubMed ID: 33327910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation.
    Huang B; Zhang Q; Yuan Y; Xin N; He K; Huang Y; Tang H; Gong P
    PLoS One; 2018; 13(7):e0200000. PubMed ID: 29975739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naringin ameliorates bone loss induced by sciatic neurectomy and increases Semaphorin 3A expression in denervated bone.
    Ma X; Lv J; Sun X; Ma J; Xing G; Wang Y; Sun L; Wang J; Li F; Li Y; Zhao Z
    Sci Rep; 2016 Apr; 6():24562. PubMed ID: 27109829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
    Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
    Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
    Cai X; Xing J; Long CL; Peng Q; Humphrey MB
    J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoregulation of Osteocyte Sema3A Orchestrates Estrogen Action and Counteracts Bone Aging.
    Hayashi M; Nakashima T; Yoshimura N; Okamoto K; Tanaka S; Takayanagi H
    Cell Metab; 2019 Mar; 29(3):627-637.e5. PubMed ID: 30661929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the effects of semaphorin 3A on new bone formation in a rat calvarial defect model.
    Kenan S; Onur ÖD; Solakoğlu S; Kotil T; Ramazanoğlu M; Çelik HH; Ocak M; Uzuner B; Fıratlı E
    J Craniomaxillofac Surg; 2019 Mar; 47(3):473-483. PubMed ID: 30616935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.